Anna MacDonald - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Anna MacDonald's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Anna MacDonald
Verified
Senior Science Editor, Technology Networks
Beats
Politics, Switzerland, IT-SecurityIT, E-Government, IT-Channel Innovation, Economy, Communication Startups, Technology, ICT Artificial Intelligence
Content
By Molly Coddington Verified, Anna MacDonald Verified| Technology Networks Verified Whilst the production of a safe and effective vaccine for SARS-CoV-2 is the ultimate aim of the COVID-19 response, research is also underway to develop novel treatments that could help infected patients in the meantime.
By Laura Elizabeth Lansdowne, Anna MacDonald Verified| Technology Networks Verified A group of eleven international medical research organizations is investigating the role that neutrophil extracellular traps (NETs) may play in the development and severity of COVID-19. The NETwork consortium recently published a paper outlining their hypothesis that overactive neutrophils could be responsible for the severe symptoms seen in some COVID-19 patients.
By Laura Elizabeth Lansdowne, Anna MacDonald Verified| Technology Networks Verified Learning more about SARS-CoV-2, the novel coronavirus behind the current COVID-19 pandemic, is a crucial part of global efforts to battle the outbreak. Understanding the virus’ biology and learning how it infects cells and spreads within tissue will help researchers on their quest to develop successful anti-viral strategies. In order to undertake these studies, scientists need an effective modeling platform, composed of the types of human cells that the virus would encounter in the body.
Company Info
Technology Networks
Technology Networks is a UK-based online scientific community that connects scientists with the latest news, articles, and resources in various fields of science. The platform offers engaging content related to drug discovery, medical research, and environmental studies, making it a valuable resource for researchers. In addition to providing scientific content, Technology Networks conducts interviews and discussions with industry leaders and experts, enhancing the dialogue around advancements in science. The company is registered as Technology Networks Limited and has been active since its incorporation in March 2000. It employs between 51 and 200 people and generates revenue in the range of $10 million to $15.2 million.
Sudbury, England, United Kingdom
+44 178 731 9234
Founded: 2000